What is the Org number of APPSENS AS?

APPSENS AS is registered with Brønnøysundsregistrene under Org 918707719.

What is the revenue of APPSENS AS?

APPSENS AS reported revenue of NOK 10,8M in 2025.

APPSENS AS employs 8 people as of the latest annual report.

Tord Ytterdahl is the CEO of APPSENS AS, in role since 2018.

Morten Andresen chairs the board of APPSENS AS, in role since 2024.

APPSENS AS's registered address is Senterveien 30, 4790 Lillesand.

ASActive

Org 918707719Senterveien 30, 4790 LillesandManufacture of pharmaceutical preparations· NACE 2120Est. 2017 · 9 years old8 employees

Actively employed in the business

Name	Role	Member since
Current (1)
TY Tord Ytterdahl Chief Executive Officer	Chief Executive Officer	2018

Non-executive oversight

Name	Role	Member since
Current (6)
AK Andreas Karlsen Eskeland Board of Directors	Board of Directors	2024
AT Anita Tunold Board of Directors	Board of Directors	2023
HM Harald Moræus-Hanssen Board of Directors	Board of Directors	2023
MA Morten Andresen Chairman	Chairman	2024
LP Lars Peder Fosse Fensli Board of Directors	Board of Directors	2024
AK Axel Kogstad Bendvold Board of Directors	Board of Directors	2023
Former (3)
BB Bjørn Breien Board of Directors	Board of Directors	2021 – 2023
TR Thomas Ramdahl Chairman	Chairman	2023 – 2023
ÅN Åge Nærdal Board of Directors	Board of Directors	2021 – 2023

As of last annual report

Shareholder	Type	Ownership	Votes	Since
Uthalden As	Company	20.11%	20.11%	2025
Agder Seed As	Company	11.87%	11.87%	2025
Fensli Consulting As	Company	11.07%	11.07%	2025
Bjørn Breien As	Company	11.07%	11.07%	2025
Lucellum As	Company	6.55%	6.55%	2025
Corsult As	Company	5.82%	5.82%	2025
Verd Investering As	Company	4.95%	4.95%	2025
Erbe Invest As	Company	4.1%	4.1%	2025
Gremsdalen Invest As	Company	3.54%	3.54%	2025
Gumpens Invest As	Company	3.05%	3.05%	2025
Ma-Invest As	Company	1.7%	1.7%	2025
Fensli Invest As	Company	1.48%	1.48%	2025
Contina As	Company	1.38%	1.38%	2025
Sollys Invest As	Company	1.19%	1.19%	2025

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.